• Aucun résultat trouvé

Modifications of the endosomal compartment in peripheral blood mononuclear cells and fibroblasts from Alzheimer’s disease patients

N/A
N/A
Protected

Academic year: 2021

Partager "Modifications of the endosomal compartment in peripheral blood mononuclear cells and fibroblasts from Alzheimer’s disease patients"

Copied!
9
0
0

Texte intégral

Loading

Figure

Table 1. Demographic and clinical data of analysed groups
Figure 2a shows the percentage of cells with MEV of the three classes for the three groups
Figure 3. Correlation between mean endosomal volume in AD patients (AD-MCI and AD-D) and their PiB retention
Figure 4. Endosomal abnormalities are present in fi broblasts from individuals with AD-D

Références

Documents relatifs

Neil Cashman, one of Canada’s foremost experts in neu- rodegenerative diseases has concluded: “A new era in diagnosis and treatment of propagated protein misfold- ing disorders is

The GenetiKit research team, a group of family physicians, genetic counselors and geneticists, designed the Gene Messenger series to pro- vide practical information to help

In the Canadian Study of Health and Aging (a prospective cohort study), regular physical activity, compared with no exercise, was associated with lower risk of cognitive

Expressions of adenosine A2A receptors in coronary arteries and peripheral blood mononuclear cells are correlated in coronary artery disease patients.. Adenosine strongly impacts

The aim of the present study was to optimize a cell culture protocol (including quantity of cells, culture duration, and positive control) to obtain reproducible cytokine and

For example, the leave-on out cross validation accuracy obtained on training data is about 81 % for classifying (Alzheimer Disease) AD versus Normal control (NC) and

Our results demonstrate that the gene expression of CD200R, F13A1, TGF, AMAC1, CD163 and MR, all established markers for the alternative differentiation, was

These results demonstrated a dichotomy between biliverdin reductase-A protein levels and activity in the hippocampus of subjects affected by Alzheimer disease and mild